CLINIMACS CELL FACTORY
LIVE

Serial Number

79279344

Owner

Miltenyi Biotec GmbH

Filing Date

Oct 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CLINIMACS CELL FACTORY Trademark

Serial Number: 79279344 • Registration: 6242135

CLINIMACS CELL FACTORY is a trademark filed by Miltenyi Biotec GmbH on October 10, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Miltenyi Biotec GmbH (30 trademarks)

Friedrich-Ebert-Strabe 68
51429 Bergisch Gladbach , DE

Entity Type: 03

MILTENYI BIOTEC B.V. & CO. KG (38 trademarks)

BERGISCH GLADBACH 51429 , DE

Entity Type: 30

Trademark Details

Filing Date

October 10, 2019

Registration Date

January 12, 2021

Published for Opposition

October 27, 2020

Goods & Services

Scientific and technological services, namely, research and design in the field of computer hardware and software for the analysis of biological and biochemical materials ; industrial analysis and research services; design and development of computer hardware and computer software, all of the aforesaid services for and in connection with the analysis of biological material, in particular cell material for biological and medical research and therapy; scientific services relating to the isolation and cultivation of cell materials for biological and medical research and therapy; design and development of laboratory processes for manufacturing cell products; design and development of computer hardware and software, in connection with manufacturing cell preparations, selecting, stimulating, activating cells for medical, scientific, pharmaceutical or biotechnological purposes, and products necessary therefor; development of software in the field of molecular biology; biotechnological laboratory services, in particular in connection with manufacturing cell therapy products, cell preparations, cellular medicines, selecting, stimulating, activating cells, and manufacturing kits or reagents; chemistry, biology and molecular biology laboratory services; design and development of manufacturing processes for medical cell preparations

Chemicals and/or biological preparations for use in industry and science; diagnostic preparations for scientific or research use including medical laboratory diagnosis; chemicals, biological and biochemical preparations for use in separation processes for biological materials, in particular nucleic acid for laboratory use; reagents for scientific and research use, namely, reagents for cell separation, labelling reagents; chemicals for scientific use and for use in medical laboratories for use in separation processes for biological materials; molecules of microorganisms including viruses, bacteria, fungi, in particular proteins, peptides, and protein and peptide pools, oligosaccharides, lipids, hybridization solutions, chemical preparations for cleaning purposes, cDNA clones, all for use in industry and science; reagents, chemical and/or biological media, materials and components for preparing media, all of the aforesaid for industrial and scientific purposes and for use in medical laboratories; reagents for use in science and/or industry for processing, separating, isolating, enriching, expanding, differentiating, depleting, detecting, screening, analyzing and tallying material, in particular chemicals and biological material, reagents featuring magnetic beads, antibody reagents; buffer solutions and reagents for use with laboratory apparatus, in particular separation apparatus, analyzers, reactors, cell processing apparatus and imaging apparatus; reagents for use in science and/or industry for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; chemical reagents and preparations for use in the manufacture of medicines; culture media, cell culture media, freezing media for in vivo scientific use; reagents other than for medical purposes for use in biotechnology, in biological processing operations and in the biotechnology industry, and the manufacture of medicine; chemicals and biological preparations for use in industry and science; diagnostic preparations for scientific or research use; chemical and/or biological substances and mixtures for industrial and scientific applications in preparing media; culture media for scientific use, namely, biology, microbiology, and for use in the biotechnical industry and in medical research; chemical preparations for use in pharmaceutical and medical science; reagents for clinical and non-clinical laboratory use, in particular cytokines and antibodies

Medical apparatus and instruments, namely, apparatus and instruments for magnetic cell separation for medical purposes; apparatus and instruments for medical use, in particular an automated system for processing cells; blood tube sets for medical purposes; analysis columns for medical purposes, for blood analysis; incubation units for medical purposes; bio-reactors for medical purposes for cell culturing; component and replacement parts for the aforesaid goods; medical apparatus for extracorporeal immunoadsorption; medical apparatus and equipment for extracorporeal plasma therapy and component and replacement parts and fittings therefor, in particular sterile bottles, filters, membrane filters, cannulae and tubes for medical purposes, being replaceable parts; chromatography columns for medical use, in particular adsorption columns and cartridges for use in extra-corporal plasma therapy; medical apparatus and equipment for separating plasma and component and replacement parts and fittings therefor, in particular sterile bottles, filters, membrane filters and tubes for medical purposes, being replaceable parts; extracorporeal plasma therapy systems for medical purposes comprised of units for separating plasma, plastic containers and bags for plasma for medical purposes, plasma filter and collecting tubes, sterile filters for medical purposes, control units, microprocessors, pumps, monitors, pH detectors, air detectors and photodetectors, optical detectors; medical apparatus in the nature of absorber cartridges and columns for use in extracorporeal plasma therapy; medical apparatus and equipment for separating plasma; apparatus for magnetic cell separation for medical purposes; sacks, pouches, bags, foils, hoses and connectors adapted for medical use, in particular for cryopreservation of human cells and human tissues; chromatography columns for medical use, in particular immune adsorption columns for ex-vivo application in therapy; medical measuring apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; component and replacement parts for the aforesaid goods

Medical and pharmaceutical compounding services; medical, pharmaceutical laboratory services, in particular providing medical and pharmaceutical consultation in connection with manufacturing cell therapy products, cell preparations, cellular medicines, selecting, stimulating, activating cells, and manufacturing kits or reagents; medical services, in particular in the field of extracorporeal plasma therapy; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Scientific apparatus and instruments for magnetic cell separation for use in clinical and non-clinical laboratories; apparatus and instruments for use in clinical and non-clinical laboratories, in particular an automated system for processing cells; test tube sets for scientific purposes; chromatography columns for laboratory use; laboratory centrifuges; laboratory incubators; laboratory bioreactors; component and replacement parts for all the mentioned goods; scientific, electric and electronic apparatus and instruments for separating biological material for scientific use, in particular for separating cells and biological macro-molecules, in particular proteins, nucleic acids; scientific, electric and electronic apparatus and instruments for conducting enzymatic reactions for scientific use; liquid and gas analyzers, and recorded control software, laboratory pipetting stations and laboratory sample carrier plates therefor; scientific apparatus and instruments for magnetically sorting biological material, and computer hardware and recorded computer operating software therefor; cell separation and cell processing apparatus for laboratory use; cytometers; microchips and data carriers containing recorded software for use with gene detecting apparatus, namely, for indicating pathological changes; microchips in the form of coated glass slides or plastic materials; microchips and testing instruments for the diagnostic detection of gene expression profiles indicative of pathological changes for scientific research use; electric and electronic apparatus and instruments for cell separation and for cell processing, for use in clinical and non-clinical laboratories; sacks, pouches, bags and films specially adapted for the holding of cell culture and biotechnological preparations for scientific or laboratory use, in particular for cryopreservation; component and replacement parts for all the mentioned goods

Pharmaceutical and medical preparations for the treatment of cancer, heart disease, diabetes, and blood disorders; biochemical, in particular immunological preparations in the nature of immunostimulants, vaccines, and cells for medical and pharmaceutical purposes; absorbents for therapeutic purposes in the field of extracorporeal plasma treatment, namely, peptide adsorbents; pharmaceutical preparations and pharmaceuticals in the field of extracorporeal plasma therapy, namely, blood purifying preparations, extracorporeal plasma therapy solutions, physiological saline solutions, glycine solutions, PBS solutions, preparations for extending blood coagulation time, heparin solutions; biochemical preparations for medical and pharmaceutical purposes in the field of extracorporeal plasma, in particular immunological preparations for the prevention and treatment of diseases and disorders of the immune system; reagents and cell growth media, and substances and components for the preparation of cell growth media, all being for medical purposes; reagents for processing, separating, isolating, enriching, depleting, detecting, expanding, differentiating, screening, analyzing and tallying biological material, reagents containing magnetic beads, and antibody reagents, all for medical purposes; buffer solutions and reagents for use with medical apparatus, in particular separation apparatus, analyzers, reactors, cell processing apparatus and imaging apparatus; reagents for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof, all being for medical purposes; reagents for medical use and preparations for medical purposes for the treatment of cancer, heart disease, diabetes and blood disorders; culture media for cultivating human cells and human tissue, cell culture media for cultivating human cells and human tissue, freezing media for the cryopreservation of human cells and human tissue, contrast agents and contract agents for in vivo imaging, all of the aforesaid goods for medical, pharmaceutical purposes; cellular medicines and pharmaceutical treatments for the treatment of cancer, heart disease, diabetes and blood disorders; chemical, biochemical and biological preparations for pharmaceutical and medical purposes for the treatment of cancer, heart disease, diabetes, and blood disorders; molecules of microorganisms including viruses, bacteria, fungi, in particular proteins, peptides, and protein and peptide pools, all for medical purposes; freezing preparations for medical purposes for the cryopreservation of human cells and human tissues; diagnostic preparations and substances for medical purposes; media for cell culture for cultivating human cells and human tissue; media for bacteriological cultures for medical purposes; cell cultures, fungal cultures and virus cultures, all for medical purposes; pharmaceuticals for cellular therapy; reagents for medical use, in particular cytokines and antibodies

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 12, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 11, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 19, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 19, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 12, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 12, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 27, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 27, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Oct 25, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 7, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 7, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 7, 2020 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 23, 2020 PREV
CHANGE OF OWNER RECEIVED FROM IB
Sep 18, 2020 CHLD
ASSIGNED TO LIE
Sep 16, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 3, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 3, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 3, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 3, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 3, 2020 ZZZX
WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
Aug 29, 2020 ISSR
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 28, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 6, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 6, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 6, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 6, 2020 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 10, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 29, 2020 MAFR
ASSIGNED TO EXAMINER
Feb 25, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2020 REPR